Medication info
Telmido Duo Plus Tablet 80/5/5 mg

Telmido Duo Plus Tablet 80/5/5 mg

Prescription medicationTabletOral
Ingredient · strength
Telmisartan›80mg / 1 tabletAmlodipine Besylate›6.935mg / 1 tabletRosuvastatin Calcium Micronized›5.2mg / 1 tablet
Manufacturer / importer
Jeil Pharmaceutical Co., Ltd.
Appearance
Oval bicolored tablet consisting of a white layer and a light blue layer
Packaging
30 tablets/box [10 tablets/PTPx3], 30 tablets/bottle
Approval status
Active

MFDS item code 202302797 · Approved 2023.09.21 · Insurance code 645406410

Summary

Main use
Treatment of hypertension, improvement of dyslipidemia, and inhibition of atherosclerosis progression and cardiovascular disease risk
Who takes it
Adults
Adult dose
Take 1 tablet once daily with water, regardless of meals. If possible, it is recommended to take the medicine at the same time each day (e.g., in the morning). This medicine is for adults only. The dose should be individualized for each patient based on the efficacy and tolerability of the telmisartan/amlodipine combination and rosuvastatin. For patients taking telmisartan/amlodipine combination therapy together with rosuvastatin as a single-ingredient product, they may switch to this medicine (a combination product with the same amount of each active ingredient) for convenience. ○ Telmisartan/amlodipine combination Before administering the telmisartan/amlodipine combination, it is recommended to adjust the dose using the individual components (amlodipine or telmisartan). However, if blood pressure is not controlled with the individual components as described below, switching directly to the telmisartan/amlodipine combination may be considered. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. - 80/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or this medicine 40/10 mg. ◦ Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. In patients with severe renal impairment, however, it is recommended to start treatment at a lower dose and increase the dose gradually. ◦ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Elderly patients: In elderly patients aged 75 years or older, amlodipine clearance is reduced; therefore, start treatment at a lower dose and increase the dose gradually. ○ Rosuvastatin 1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with rosuvastatin and continue it throughout the treatment period. Rosuvastatin may be taken at any time of day, with or without food. The initial dose is 5 mg once daily. If a greater reduction in LDL cholesterol is needed, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 mg once daily, which is sufficient to control the condition in most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and the patient's response; it may be increased to a maximum of 20 mg daily. 2. Elderly patients: No dose adjustment is necessary. 3. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Exercise particular caution when administering rosuvastatin 20 mg to patients with moderate renal impairment. 4. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer rosuvastatin to patients with active liver disease. 5. Race: Because systemic exposure to rosuvastatin is increased in Asian patients, the recommended initial dose is 5 mg. Administration of the 40 mg dose is contraindicated. 6. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 mg. Administration of the 40 mg dose of rosuvastatin is contraindicated in some of these patients.

Ingredients

Manufacturer
Jeil Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of hypertension, improvement of dyslipidemia, and inhibition of atherosclerosis progression and cardiovascular disease risk

  • Essential hypertension
  • primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • combined hyperlipidemia
  • homozygous familial hypercholesterolemia
  • hypercholesterolemia
  • primary dysbetalipoproteinemia
  • elevated high-sensitivity C-reactive protein
  • hypertension
  • low HDL-cholesterol levels
  • smoking
  • family history of early coronary artery disease
View approved original text

This medication is used in patients with essential hypertension whose blood pressure control is insufficient with the combination of telmisartan and amlodipine alone, and who also need to take rosuvastatin simultaneously. The combination of telmisartan and amlodipine effectively lowers essential hypertension and aids in blood pressure control. Rosuvastatin lowers blood cholesterol and LDL-cholesterol levels in patients with hypercholesterolemia and dyslipidemia, thereby improving vascular health. Additionally, in patients with hypercholesterolemia, it delays the progression of atherosclerosis and helps patients with refractory lipid disorders such as homozygous familial hypercholesterolemia. In patients at high risk of cardiovascular disease, it is also used to reduce the risk of complications following a stroke, myocardial infarction, or artery revascularization. This medication contributes to cardiovascular health by effectively managing hypertension and hyperlipidemia.

How to take

Adult dose

Take 1 tablet once daily with water, regardless of meals. If possible, it is recommended to take the medicine at the same time each day (e.g., in the morning). This medicine is for adults only. The dose should be individualized for each patient based on the efficacy and tolerability of the telmisartan/amlodipine combination and rosuvastatin. For patients taking telmisartan/amlodipine combination therapy together with rosuvastatin as a single-ingredient product, they may switch to this medicine (a combination product with the same amount of each active ingredient) for convenience. ○ Telmisartan/amlodipine combination Before administering the telmisartan/amlodipine combination, it is recommended to adjust the dose using the individual components (amlodipine or telmisartan). However, if blood pressure is not controlled with the individual components as described below, switching directly to the telmisartan/amlodipine combination may be considered. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. - 80/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or this medicine 40/10 mg. ◦ Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. In patients with severe renal impairment, however, it is recommended to start treatment at a lower dose and increase the dose gradually. ◦ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Elderly patients: In elderly patients aged 75 years or older, amlodipine clearance is reduced; therefore, start treatment at a lower dose and increase the dose gradually. ○ Rosuvastatin 1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with rosuvastatin and continue it throughout the treatment period. Rosuvastatin may be taken at any time of day, with or without food. The initial dose is 5 mg once daily. If a greater reduction in LDL cholesterol is needed, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 mg once daily, which is sufficient to control the condition in most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and the patient's response; it may be increased to a maximum of 20 mg daily. 2. Elderly patients: No dose adjustment is necessary. 3. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Exercise particular caution when administering rosuvastatin 20 mg to patients with moderate renal impairment. 4. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer rosuvastatin to patients with active liver disease. 5. Race: Because systemic exposure to rosuvastatin is increased in Asian patients, the recommended initial dose is 5 mg. Administration of the 40 mg dose is contraindicated. 6. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 mg. Administration of the 40 mg dose of rosuvastatin is contraindicated in some of these patients.

Precautions

This medication can cause serious harm to the fetus when taken during pregnancy; therefore, it should be discontinued immediately upon confirmation of pregnancy. Do not take if you have an allergy to any of the ingredients in this medication or similar medications. Patients with severe liver or kidney impairment, a history of angioedema, or certain muscle disorders may be at risk if they use this medication, and should avoid taking it. Elderly individuals or patients with noticeably low blood pressure, minor renal or liver dysfunction should be monitored closely while taking this medication. If symptoms such as muscle pain, weakness, or cramps arise while using this medication, consult a physician immediately, and if necessary, conduct blood tests to check for muscle damage. Periodic liver function tests should be conducted if liver dysfunction is suspected, and the medication should be discontinued if liver enzyme levels increase significantly. This medication may interact with other drugs, so be sure to inform your doctor or pharmacist, especially if you are taking blood pressure medication, diuretics, certain antibiotics, antifungals, immunosuppressants, or anticoagulants. It is advisable for nursing women not to take this medication; if necessary, breastfeeding should be stopped. It is not recommended for children under 18 years of age as safety and effectiveness have not been sufficiently established. In case of overdose, symptoms such as hypotension, dizziness, and arrhythmia may occur, so immediate medical attention should be sought.

Side effects

Peripheral edema, dyspepsia, frequent bowel movements, diabetes, dizziness, dry vesicular sound, urticaria, unstable angina, onychomycosis, lumbar spinal stenosis, ear discharge, vertigo, chronic gastritis, hiatal hernia, musculoskeletal pain, neck pain, nasopharyngitis, upper abdominal discomfort, upper abdominal pain, orthostatic dizziness, dysuria, rhinitis, discomfort in the oral cavity and pharynx, lung disease, indeterminate intestinal disease, benign gastrointestinal neoplasm, hemorrhoids, skeletal pain, osteoporosis, sensory loss, movement disorders, atherosclerosis, polyuria, tinnitus, hearing loss, bad breath, fatty liver, upper respiratory infection, back pain, sinusitis, diarrhea, pharyngitis, influenza-like symptoms, myalgia, urinary tract infection, abdominal pain, headache, dizziness, pain, fatigue, cough, hypertension, chest pain, nausea, palpitations, dependent edema, angina, rapid pulse, leg swelling, abnormal ECG, insomnia, drowsiness, migraine, dizziness, sensory abnormalities, involuntary muscle contractions, sensory loss, flatulence, constipation, gastritis, vomiting, dry mouth, hemorrhoids, gastroenteritis, enteritis, gastroesophageal reflux, toothache, nonspecific gastrointestinal disease, gout, hypercholesterolemia, anxiety, depression, irritability, infection, fungal infection, abscess, otitis media, asthma, bronchitis, rhinitis, shortness of breath, epistaxis, dermatitis, rash, eczema, pruritus, vascular edema, erythema multiforme, erythematous rash, papular rash, frequent urination, cystitis, leukopenia, purpura, thrombocytopenia, erectile dysfunction, vascular edema, headache, edema, fatigue, nausea, abdominal pain, drowsiness, arrhythmia, bradycardia, chest pain, peripheral ischemia, syncope, orthostatic hypotension, vasculitis, peripheral neuropathy, tremor, loss of appetite, swallowing difficulties, pancreatitis, gingival hyperplasia, asthenia, burning sensation, lethargy, stiffness, weight gain, weight loss, arthralgia, osteoarthritis, muscle cramps, sexual dysfunction, insomnia, irritability, abnormal dreams, depersonalization, shortness of breath, epistaxis, vascular edema, pruritus, skin dryness, hair loss, dermatitis, muscle weakness, single contraction, coordination abnormality, muscular hypertonia, cold and moist skin, apathy, anxiety, amnesia, gastritis, increased appetite, loose stools, rhinitis, urinary dysfunction, polyuria, abnormal olfaction, taste disturbance, abnormal eye movement control, dry eye syndrome, headache, dizziness, asthenia, cough, nausea, fatigue, weakness, edema, facial swelling, lower limb swelling, vascular edema, pruritus, hypersensitivity, increased sweating, erythema, chest pain, atrial fibrillation, congestive heart failure, myocardial infarction, elevated blood pressure, worsening hypertension, hypotension, hyperkalemia, hypoglycemia, syncope, dyspepsia, diarrhea, urinary tract infection, erectile dysfunction, back pain, abdominal pain, muscle cramps, myalgia, bradycardia, eosinophilia, thrombocytopenia, elevated uric acid, liver dysfunction, liver disease, acute renal failure, anemia, elevated CPK, anaphylactic reaction, tendon pain, rhabdomyolysis, vascular edema, thrombocytopenia, jaundice, hepatitis, Stevens-Johnson syndrome, eosinophilia and systemic symptomatology drug reaction syndrome, lupus-like syndrome, muscle rupture, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, liver failure, memory decline, forgetfulness, amnesic syndrome, memory impairment, confusion, myasthenia gravis, oculobulbar weakness

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is packaged in materials that protect it from light and air, and should be stored at room temperature between 1°C and 30°C. It is important to store the medication in a cool place, avoiding direct sunlight and extreme temperatures.

Appearance and packaging

Appearance

Oval bicolored tablet consisting of a white layer and a light blue layer

Package unit

30 tablets/box [10 tablets/PTPx3], 30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.